Search Results
Search for other papers by R Dobie in
Google Scholar
PubMed
Search for other papers by V E MacRae in
Google Scholar
PubMed
Search for other papers by C Huesa in
Google Scholar
PubMed
Search for other papers by R van't Hof in
Google Scholar
PubMed
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by C Farquharson in
Google Scholar
PubMed
Roith et al . 2001 ). The intimate relationship between GH and IGF1 makes it difficult to deduce the relative contributions of systemic and locally derived IGF1 to bone accrual. While Ghr −/− mice have recognised changes in skeletal mass and
Search for other papers by Bernard Freudenthal in
Google Scholar
PubMed
Search for other papers by John Logan in
Google Scholar
PubMed
Search for other papers by Sanger Institute Mouse Pipelines in
Google Scholar
PubMed
Search for other papers by Peter I Croucher in
Google Scholar
PubMed
Search for other papers by Graham R Williams in
Google Scholar
PubMed
Search for other papers by J H Duncan Bassett in
Google Scholar
PubMed
al . 2009 ). The most important risk factors for osteoporotic fracture are low bone mineral density (BMD) (clinically assessed by dual-energy X-ray absorptiometry (DEXA or DXA)), increasing age and history of fracture ( Johnell et al . 2005
Search for other papers by K A Staines in
Google Scholar
PubMed
Search for other papers by A S Pollard in
Google Scholar
PubMed
Search for other papers by I M McGonnell in
Google Scholar
PubMed
Search for other papers by C Farquharson in
Google Scholar
PubMed
Search for other papers by A A Pitsillides in
Google Scholar
PubMed
Introduction The transition of cartilage to bone is the basis by which all long bones form. This transition is tightly regulated to ensure both permissive foetal development through endochondral ossification and postnatal longitudinal growth at the
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Carmen Corciulo in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Julia M Scheffler in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Piotr Humeniuk in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Alicia Del Carpio Pons in
Google Scholar
PubMed
Search for other papers by Alexandra Stubelius in
Google Scholar
PubMed
Search for other papers by Ula Von Mentzer in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Christina Drevinge in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Aidan Barrett in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Sofia Wüstenhagen in
Google Scholar
PubMed
Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, Turku Center for Disease Modeling, University of Turku, Turku, Finland
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Department of Drug Treatment, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Marie K Lagerquist in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ulrika Islander in
Google Scholar
PubMed
associated with structural subchondral bone damage, increased pain sensitivity also in body parts that are not directly affected by the disease, and mild inflammation of the synovium ( Loeser et al. 2012 ). OA affects more than 240 million people globally
Search for other papers by Andrea Lovdel in
Google Scholar
PubMed
Search for other papers by Karla J Suchacki in
Google Scholar
PubMed
Search for other papers by Fiona Roberts in
Google Scholar
PubMed
Search for other papers by Richard J Sulston in
Google Scholar
PubMed
Search for other papers by Robert J Wallace in
Google Scholar
PubMed
Search for other papers by Benjamin J Thomas in
Google Scholar
PubMed
Search for other papers by Rachel M B Bell in
Google Scholar
PubMed
Search for other papers by Iris Pruñonosa Cervera in
Google Scholar
PubMed
Search for other papers by Gavin J Macpherson in
Google Scholar
PubMed
Centre for Systems Health and Integrated Metabolic Research, Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK
Search for other papers by Nicholas M Morton in
Google Scholar
PubMed
Search for other papers by Natalie Z M Homer in
Google Scholar
PubMed
Search for other papers by Karen E Chapman in
Google Scholar
PubMed
Search for other papers by William P Cawthorn in
Google Scholar
PubMed
Introduction Bone marrow adipocytes comprise up to 70% of total bone marrow (BM) volume and over 10% of total adipose mass in healthy adult humans, collectively forming an integrated tissue referred to as bone marrow adipose tissue (BMAT
Search for other papers by Karin L Gustafsson in
Google Scholar
PubMed
Search for other papers by Sofia Movérare-Skrtic in
Google Scholar
PubMed
Search for other papers by Helen H Farman in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Cecilia Engdahl in
Google Scholar
PubMed
Search for other papers by Petra Henning in
Google Scholar
PubMed
Search for other papers by Karin H Nilsson in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Julia M Scheffler in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Edina Sehic in
Google Scholar
PubMed
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Search for other papers by Ulrika Islander in
Google Scholar
PubMed
Department of Veterans Affairs Medical Center, Long Beach, Long Beach, California, USA
Search for other papers by Ellis Levin in
Google Scholar
PubMed
Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Marie K Lagerquist in
Google Scholar
PubMed
-generation SERMs, have agonistic effects in bone and can prevent both vertebral and non-vertebral fractures in humans ( Cummings et al. 2010 , Silverman et al. 2012 ). Animal studies have also shown positive effects of these SERMs at both vertebral and non
Search for other papers by Thomas Funck-Brentano in
Google Scholar
PubMed
Search for other papers by Karin H Nilsson in
Google Scholar
PubMed
Search for other papers by Robert Brommage in
Google Scholar
PubMed
Search for other papers by Petra Henning in
Google Scholar
PubMed
Search for other papers by Ulf H Lerner in
Google Scholar
PubMed
Search for other papers by Antti Koskela in
Google Scholar
PubMed
Search for other papers by Juha Tuukkanen in
Google Scholar
PubMed
Search for other papers by Martine Cohen-Solal in
Google Scholar
PubMed
Search for other papers by Sofia Movérare-Skrtic in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
was followed by further evidence of the role of WNTs in the tumorigenesis of various human cancers in β-catenin-dependent or -independent pathways ( Anastas & Moon 2012 ). The importance of the WNT signaling pathway in bone homeostasis was highlighted
Search for other papers by K L Gustafsson in
Google Scholar
PubMed
Search for other papers by K H Nilsson in
Google Scholar
PubMed
Search for other papers by H H Farman in
Google Scholar
PubMed
Search for other papers by A Andersson in
Google Scholar
PubMed
Search for other papers by V Lionikaite in
Google Scholar
PubMed
Search for other papers by P Henning in
Google Scholar
PubMed
Search for other papers by J Wu in
Google Scholar
PubMed
Search for other papers by S H Windahl in
Google Scholar
PubMed
Search for other papers by U Islander in
Google Scholar
PubMed
Search for other papers by S Movérare-Skrtic in
Google Scholar
PubMed
Search for other papers by K Sjögren in
Google Scholar
PubMed
Search for other papers by H Carlsten in
Google Scholar
PubMed
Search for other papers by J-Å Gustafsson in
Google Scholar
PubMed
Search for other papers by C Ohlsson in
Google Scholar
PubMed
Search for other papers by M K Lagerquist in
Google Scholar
PubMed
Introduction Estrogen, the main female reproductive hormone, is a major regulator of bone homeostasis and it is well known that estrogen deficiency after menopause increases fracture risk and that estrogen treatment decreases this risk
Search for other papers by Lina Lawenius in
Google Scholar
PubMed
Search for other papers by Hannah Colldén in
Google Scholar
PubMed
Search for other papers by Karin Horkeby in
Google Scholar
PubMed
Search for other papers by Jianyao Wu in
Google Scholar
PubMed
Search for other papers by Louise Grahnemo in
Google Scholar
PubMed
Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia
Search for other papers by Liesbeth Vandenput in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Klara Sjögren in
Google Scholar
PubMed
Introduction Osteoporosis is a debilitating disease affecting one in two women and one in five men after 50 years of age ( Sambrook & Cooper 2006 ). Both men and women lose bone in an age-dependent manner because of decreasing sex hormone
Search for other papers by Vikte Lionikaite in
Google Scholar
PubMed
Search for other papers by Karin L Gustafsson in
Google Scholar
PubMed
Search for other papers by Anna Westerlund in
Google Scholar
PubMed
Search for other papers by Sara H Windahl in
Google Scholar
PubMed
Search for other papers by Antti Koskela in
Google Scholar
PubMed
Search for other papers by Juha Tuukkanen in
Google Scholar
PubMed
Search for other papers by Helena Johansson in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by H Herschel Conaway in
Google Scholar
PubMed
Search for other papers by Petra Henning in
Google Scholar
PubMed
Search for other papers by Ulf H Lerner in
Google Scholar
PubMed
Wiseman et al. 2017 ). In humans, increased vitamin A consumption and elevated serum retinol levels have been associated with increased bone fragility and fracture risk ( Melhus et al. 1998 , Whiting & Lemke 1999 , Feskanich et al. 2002